Neuralink Corp.
5 private offerings reported to the SEC on Form D since 2016, $1.2B sold in all. Biotech, CA.
- Form D offerings: 5
- Reported sold: $1.2B
- Newest: Jun 12, 2025
Every Form D Offering
Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.| Jun 12, 2025 | $649.0M | $649.0M | Neuralink Corp.Biotech · CA | Not amended | 0001708503-25-000003 |
| Aug 8, 2023 | $323.2M | $323.2M | Neuralink Corp.Biotech · CA | Nov 22, 2023 | 0001708503-23-000001 |
| Aug 4, 2021 | $205.9M | $205.9M | Neuralink Corp.Biotech · CA | Not amended | 0001708503-21-000002 |
| May 10, 2019 | $39.3M | $51.3M | Neuralink Corp.Biotech · CA | Not amended | 0001708503-19-000001 |
| Aug 25, 2017 | $27.0M | $100.2M | Neuralink Corp.Biotech · CA | Not amended | 0001708503-17-000001 |
SEC Profile
From the company's EDGAR record- Business address
- Fremont, Ca
- Incorporated in
- NV
- All SEC filings
- CIK 1708503 on EDGAR
A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR